Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study-Reference-Cited by-同舟云学术

Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study

Published:2024-01-15 Issue: Volume: Page:
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sharma Akshay^ORCID,Galimard Jacques-Emmanuel^ORCID,Pryce Angharad,Bhoopalan Senthil Velan^ORCID,Dalissier Arnaud,Dalle Jean-Hugues,Locatelli Franco^ORCID,Jubert Charlotte,Mirci-Danicar Oana,Kitra-Roussou Vassiliki,Bertrand Yves,Fagioli Franca^ORCID,Rialland Fanny^ORCID,Biffi Alessandra,Wynn Robert F.^ORCID,Michel Gérard^ORCID,Tambaro Francesco Paolo^ORCID,Al-Ahmari Ali^ORCID,Tbakhi Abdelghani,Furness Caroline L.,Diaz Miguel Angel,Sedlacek Petr,Bodova Ivana,Faraci Maura^ORCID,Rao Kanchan,Kleinschmidt Katharina^ORCID,Petit Arnaud^ORCID,Gibson Brenda,Bhatt Neel S.^ORCID,Kalwak Krzysztof^ORCID,Corbacioglu Selim^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

American Lebanese Syrian Associated Charities

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-024-02197-3.pdf

Reference34 articles.

1. Rubnitz JE, Kaspers GJL. How I treat pediatric acute myeloid leukemia. Blood. 2021;138:1009–18.

2. Loken MR, Alonzo TA, Pardo L, Gerbing RB, Raimondi SC, Hirsch BA, et al. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children’s Oncology Group. Blood. 2012;120:1581–8.

3. Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29:551–65.

4. Rubnitz JE. Current management of childhood acute myeloid leukemia. Paediatr Drugs. 2017;19:1–10.

5. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood. 2009;114:2489–96.